- Home
- WDI vs AMLX Comparison
WDI vs AMLX Comparison
Compare WDI & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WDI
- AMLX
- Stock Information
- Founded
- WDI 2021
- AMLX 2014
- Country
- WDI United States
- AMLX United States
- Employees
- WDI N/A
- AMLX N/A
- Industry
- WDI Trusts Except Educational Religious and Charitable
- AMLX Biotechnology: Pharmaceutical Preparations
- Sector
- WDI Finance
- AMLX Health Care
- Exchange
- WDI Nasdaq
- AMLX Nasdaq
- Market Cap
- WDI 781.5M
- AMLX 684.6M
- IPO Year
- WDI N/A
- AMLX 2022
- Fundamental
- Price
- WDI $14.86
- AMLX $8.15
- Analyst Decision
- WDI
- AMLX Strong Buy
- Analyst Count
- WDI 0
- AMLX 7
- Target Price
- WDI N/A
- AMLX $12.00
- AVG Volume (30 Days)
- WDI 192.6K
- AMLX 2.2M
- Earning Date
- WDI 01-01-0001
- AMLX 08-07-2025
- Dividend Yield
- WDI 11.80%
- AMLX N/A
- EPS Growth
- WDI N/A
- AMLX N/A
- EPS
- WDI 1.12
- AMLX N/A
- Revenue
- WDI N/A
- AMLX N/A
- Revenue This Year
- WDI N/A
- AMLX N/A
- Revenue Next Year
- WDI N/A
- AMLX N/A
- P/E Ratio
- WDI $12.82
- AMLX N/A
- Revenue Growth
- WDI N/A
- AMLX N/A
- 52 Week Low
- WDI $12.16
- AMLX $1.76
- 52 Week High
- WDI $14.69
- AMLX $8.72
- Technical
- Relative Strength Index (RSI)
- WDI 50.04
- AMLX 64.12
- Support Level
- WDI $14.80
- AMLX $7.70
- Resistance Level
- WDI $15.12
- AMLX $8.67
- Average True Range (ATR)
- WDI 0.09
- AMLX 0.51
- MACD
- WDI -0.01
- AMLX -0.02
- Stochastic Oscillator
- WDI 22.46
- AMLX 73.55
About WDI Western Asset Diversified Income Fund of Beneficial Interest
Western Asset Diversified Income Fund is a newly-organized, diversified, closed-end management investment company. The fund's primary investment objective is to seek high current income.
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.